Okay, let's tackle this question. The question is about antibody-mediated enhancement being a feature of which disease. First, I need to recall what antibody-mediated enhancement means. From what I remember, this phenomenon occurs when antibodies that bind to a virus actually facilitate its entry into cells, making the infection worse. This is different from the usual neutralizing antibodies that prevent infection.

The core concept here is the mechanism of antibody-dependent enhancement (ADE). ADE is a process where non-neutralizing antibodies bind to a pathogen and, instead of neutralizing it, they help it enter host cells via Fc receptors. This is commonly associated with certain viruses. Now, which viruses are known for this? I think dengue virus is a classic example. Dengue can cause more severe disease during a secondary infection because of ADE. Also, maybe some other flaviviruses like Zika or SARS-CoV-2 might have similar mechanisms, but dengue is the most well-known.

The correct answer would be dengue. Let me check the options. The user hasn't provided the options, but assuming the options include dengue. Now, why are other options incorrect? If other options are, say, HIV, measles, or hepatitis B, then those don't typically involve ADE. HIV's pathogenesis is more about CD4+ T cell depletion and immune system compromise. Measles is a single infection, and hepatitis B's progression is more about immune response than ADE.

Clinical pearl: Remember that ADE is a key concept in dengue, especially in explaining why secondary infections are more severe. It's important for understanding vaccine development too, as some vaccines might inadvertently cause ADE if they induce non-neutralizing antibodies. So, the high-yield fact is that dengue and other flaviviruses are associated with antibody-dependent enhancement, leading to more severe disease upon reinfection.

**Core Concept**
Antibody-dependent enhancement (ADE) is a phenomenon where non-neutralizing antibodies facilitate viral entry into host cells via Fcγ receptors, exacerbating infection severity. It is most commonly associated with **dengue virus** (a flavivirus), where secondary infections trigger more severe disease due to cross-reactive antibodies from prior infections.

**Why the Correct Answer is Right**
Dengue virus is the prototypical agent of ADE. During a primary infection, neutralizing antibodies are produced. However, in a secondary infection with a different dengue serotype, pre-existing antibodies bind to the virus but do not neutralize it. These antibody-virus complexes are internalized by macrophages via Fcγ receptors, allowing the virus to replicate intracellularly and trigger a cytokine storm, leading to dengue hemorrhagic fever or shock syndrome. This mechanism is also implicated in other flaviviruses (e.g., Zika, SARS-CoV-2) but is most clinically significant in dengue.

**Why Each Wrong Option is Incorrect**
**Option A:** HIV pathogenesis involves CD4+ T cell depletion and immune dysregulation, not ADE.
**Option B:** Measles virus causes a single, severe infection without ADE; immunity is lifelong.
**Option C:** Hepatitis B virus progression is driven by immune-mediated liver damage, not antibody-mediated enhancement.

**Clinical Pearl / High-Yield Fact**
Remember: **D

✓ Correct Answer: B. Dengue heomorrhagic fever